Genesis Financial Group LLC Makes New $996,000 Investment in SPDR S&P Biotech ETF $XBI

Genesis Financial Group LLC purchased a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 7,800 shares of the exchange traded fund’s stock, valued at approximately $996,000.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. AQR Capital Management LLC grew its position in SPDR S&P Biotech ETF by 77.1% during the first quarter. AQR Capital Management LLC now owns 4,978 shares of the exchange traded fund’s stock valued at $404,000 after buying an additional 2,167 shares during the period. Marshall Wace LLP raised its position in SPDR S&P Biotech ETF by 102.3% in the second quarter. Marshall Wace LLP now owns 4,023 shares of the exchange traded fund’s stock worth $334,000 after acquiring an additional 179,029 shares during the period. The Manufacturers Life Insurance Company purchased a new position in shares of SPDR S&P Biotech ETF during the 2nd quarter worth $260,000. Ameriprise Financial Inc. boosted its stake in shares of SPDR S&P Biotech ETF by 123.0% during the 2nd quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock worth $72,542,000 after acquiring an additional 481,408 shares during the last quarter. Finally, EP Wealth Advisors LLC grew its position in shares of SPDR S&P Biotech ETF by 3.7% during the 2nd quarter. EP Wealth Advisors LLC now owns 5,379 shares of the exchange traded fund’s stock valued at $446,000 after acquiring an additional 193 shares during the period.

SPDR S&P Biotech ETF Stock Performance

Shares of SPDR S&P Biotech ETF stock opened at $147.91 on Thursday. SPDR S&P Biotech ETF has a one year low of $84.39 and a one year high of $165.71. The stock’s fifty day moving average is $145.48 and its 200 day moving average is $134.07. The stock has a market cap of $9.73 billion, a P/E ratio of 11.47 and a beta of 0.82.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.